I think he does, two different diseases, and finally a trial for covid with IV administration! I have said this before the care of the critically ill patient is different; VOD, metabolic degradation patterns, bio-availability. It should not be compared to the HIV experience. There is so much at stake with this trial for the company, I can't remember who posted that Brazil is paying for the trial? Does CYDY have limited input to the trial design? Is the hospital picking up the entire tab or is the government also funding?

Hopefully a surgeon friend of mine at Santa Maria in Sao Paulo gets back to me soon.